Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

Over the past decade, the Human Cell Atlas community has accomplished something that will define a generation of biology.

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

While agents like AbbVie's Humira have transformed the treatment landscape, not all patients benefit equally from the drug.

AI life science benchmark LifeSciBench, published June 17 by OpenAI with 173 PhD scientists, shows frontier models clear only ...

People communicate with each other, sometimes face to face, sometimes with a text message or phone call. Cells also communicate with each other, sometimes by touching and sometimes by sending signals ...

Mallory-Denk bodies (MDBs) are protein aggregates commonly observed in chronic liver diseases, including liver fibrosis. However, the intrahepatic crosstalk driving MDB pathogenesis and fibrosis ...

The integration of artificial intelligence (AI) and multi-omics analysis is rapidly transforming the landscape of drug research and development. In recent ...

Systems biology is a rapidly evolving discipline that examines the complex interactions underlying biological function ...

Predicting spatial transcriptomics from histology images offers cost-effective insights but faces privacy barriers preventing cross-institutional data sharing. To address this, we present privateST, a ...

Knowing the location of a gene within intact tissue or a single cell allows scientists to unlock unknown cellular functions. This information is often lost in most genetic sequencing techniques, but ...